Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting No phase listed Observational

Prevention of Bleeding in Patients With Moderate and Severe Hemophilia A Playing Sports: A Comparison Between Factor VIII and Emicizumab Prophylaxis

ClinicalTrials.gov ID: NCT05022459

Public ClinicalTrials.gov record NCT05022459. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 27, 2026, 9:09 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Prevention of Bleeding in Patients With Moderate and Severe Hemophilia A Playing Sports: A Comparison Between Factor VIII and Emicizumab Prophylaxis -STEP: SporTs Emicizumab Prophylaxis

Study identification

NCT ID
NCT05022459
Recruitment status
Recruiting
Study type
Observational
Phase
Not listed
Lead sponsor
Wayne State University
Other
Enrollment
72 participants

Conditions and interventions

Conditions

Interventions

  • Emicizumab Drug
  • FVIII Drug

Drug

Eligibility (public fields only)

Age range
6 Years to 19 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 15, 2023
Primary completion
Dec 31, 2028
Completion
Feb 28, 2029
Last update posted
Jan 15, 2026

2023 – 2029

United States locations

U.S. sites
9
U.S. states
8
U.S. cities
9
Facility City State ZIP Site status
Arkansas Children's Hospital Little Rock Arkansas 72202 Recruiting
Stanford University Palo Alto California 94304 Recruiting
Rady Children's Hospital San Diego California 92123 Recruiting
Johns Hopkins All Children's Hospital St. Petersburg Florida 33701 Recruiting
Indiana Hemophilia & Thrombosis Center Indianapolis Indiana 46260 Recruiting
Boston Children's Hospital Boston Massachusetts 02215 Recruiting
Children's Hospital of Michigan Detroit Michigan 48201 Recruiting
Cincinnati Children's Hospital Medical Center Cincinnati Ohio 45229 Recruiting
Oklahoma Center for Bleeding and Clotting Disorders Oklahoma City Oklahoma 73104 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05022459, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 15, 2026 · Synced Jun 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05022459 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →